Wednesday, November 18, 2026

Trial Master File Health Check: Is Your TMF Inspection-Ready?

Inspectors often say: "If it isn't documented, it didn't happen." The Trial Master File (TMF) is where that documentation lives. It should allow anyone – an auditor, an inspector, a future partner – to reconstruct how your trial was conducted and judge whether it was done correctly.

Under ICH E6(R3), the emphasis is on essential records that tell the trial's story, not on ticking off a fixed list of documents. Yet in many audits I find TMFs that are incomplete, disorganised or filled in only at the end of the study.

Common TMF problems

  • Documents filed months late, or only before close-out
  • Missing approvals for protocol amendments or consent versions
  • Gaps in correspondence with Ethics Committees and CDSCO
  • Monitoring visit reports without follow-up letters or action closure
  • Unsigned or undated documents
  • Inconsistencies between the sponsor TMF and the investigator site file
  • eTMF systems with poor indexing, so documents cannot be found

A quick TMF health check

Pick one site and ask these questions:

  1. Completeness: Is every expected document present for the current stage of the study?
  2. Timeliness: Were documents filed within your agreed timeline (for example, within 30 days)?
  3. Quality: Are documents legible, signed, dated and final versions?
  4. Consistency: Do dates and versions match across the TMF, site file and EC approvals?
  5. Story: Could an outsider follow the study timeline – approvals, start-up, monitoring, issues and resolutions?
  6. Retrievability: Can you find any requested document within minutes?

If you struggle with any of these for one site, it is likely the problem exists across the study.

Building a healthy TMF

  • Use a reference model. An industry-standard TMF index gives structure and avoids gaps.
  • File as you go. Make TMF filing part of each process, not a separate end-of-study task.
  • Run periodic QC. A quarterly completeness and quality review catches problems early.
  • Track metrics: completeness percentage, filing timeliness and QC error rate.
  • Assign ownership. Every document type should have a responsible person.
  • Reconcile with sites. Compare the site file with the TMF at key milestones.

Why it matters commercially

A strong TMF is not only for inspectors. If you plan to license your product, seek investment or submit data to foreign regulators, buyers and reviewers will examine your TMF. Gaps raise doubts about the entire dataset.

Independent TMF audits

An independent TMF audit before database lock or submission gives you a clear list of gaps while there is still time to fix them.

Need a TMF audit or inspection-readiness review? Write to me at anup.cra@gmail.com.

– Anup Kumar, Independent Clinical Research Auditor & Consultant, New Delhi

Tuesday, November 17, 2026

What Actually Happens During a GCP Audit? A Step-by-Step Walkthrough

The word "audit" makes many site teams nervous. In reality, a well-run GCP audit is a structured, respectful process designed to help – to find problems while they can still be fixed. Here is what actually happens.

Step 1: Planning

The audit begins long before the visit. The sponsor and auditor agree:

  • Scope – which site, vendor or process will be audited
  • Objectives – routine, for-cause, pre-inspection or close-out
  • Criteria – protocol, ICH GCP, NDCT Rules, sponsor and site SOPs

The auditor reviews the protocol, monitoring reports, deviation logs and data listings to identify areas of risk. This is where an experienced auditor adds the most value: knowing where to look.

Step 2: Audit plan and notification

The site or vendor receives an audit plan with dates, agenda, documents needed and the people the auditor wishes to meet. Good preparation by the site makes the visit efficient.

Step 3: Opening meeting

A short meeting with the PI and team to introduce the auditor, confirm the scope and agenda, and answer questions. This sets a professional, collaborative tone.

Step 4: The audit itself

Typically over one to three days, the auditor:

  • Reviews documents: investigator site file, consent forms, delegation logs, training records, EC correspondence
  • Verifies data: compares CRF data with source documents for a sample of participants
  • Checks processes: IP storage and accountability, SAE reporting, sample handling
  • Interviews staff: asks how tasks are done in practice, not just what the SOP says
  • Tours facilities: storage areas, equipment, archives

Step 5: Closing meeting

The auditor shares preliminary observations verbally. There should be no surprises in the final report. This is also the site's chance to clarify misunderstandings or provide missing documents.

Step 6: Audit report

Within an agreed time, the auditor issues a written report. Findings are usually graded:

  • Critical – affects participant safety, rights or data reliability; needs immediate action
  • Major – significant non-compliance that could affect data or safety
  • Minor – deviations from good practice that should be corrected

Each finding states the requirement, what was observed and the evidence.

Step 7: CAPA and follow-up

The site or vendor responds with corrective and preventive actions, including root cause, actions, owners and timelines. The auditor or sponsor reviews the responses and follows up until findings are closed.

What makes an audit valuable

  • Independence – findings are reported without bias
  • Risk focus – time spent where it matters most
  • Clear evidence – every finding is traceable
  • Practical recommendations – fixes that work for busy Indian sites

An audit is not a fault-finding exercise. It is the best preparation for a regulatory inspection you will ever get.

Planning an audit of a site, CRO or study in India? Write to me at anup.cra@gmail.com.

– Anup Kumar, Independent Clinical Research Auditor & Consultant, New Delhi

Monday, November 16, 2026

Choosing Sites in India: 12 Questions to Ask Before You Sign

In almost every trial that struggles, the problems can be traced back to one decision: site selection. A site that over-promises recruitment, lacks experienced staff or has weak processes will cost you time, money and data quality for the entire study.

India has many excellent investigator sites. The challenge is identifying them. Before you sign a site agreement, ask these twelve questions – and ask for evidence, not just answers.

About the investigator and team

1. How many trials has the PI conducted, and in which therapeutic areas? Ask for recent examples, not a career total.

2. Who will actually do the work? Meet the study coordinator. In practice, an experienced coordinator often matters as much as the PI.

3. How many studies is the site running right now? A site running too many competing trials in the same population will struggle to recruit for yours.

4. Are GCP training records current for all staff? Ask to see certificates.

About recruitment

5. Where will participants come from? Ask for real numbers from the site's patient database or OPD records, not estimates.

6. What was your actual recruitment versus target in your last three studies? This is the single most honest predictor of performance.

7. What are the main reasons participants drop out at your site? A good site has thought about this.

About infrastructure

8. Can you store investigational product correctly? Check temperature-controlled storage, continuous monitoring and backup power – crucial during Indian summers and power cuts.

9. What equipment and lab facilities are available? Confirm calibration records for equipment that generates study data.

10. How are source documents and records stored and protected? Look for secure, access-controlled archiving.

About compliance history

11. Which Ethics Committee will review the study, and how long does it take? Confirm the EC is registered with CDSCO and ask about typical review timelines.

12. Have you been audited or inspected recently, and what were the findings? A site that openly discusses past findings and how it fixed them is often more reliable than one that claims to have none.

Go beyond the questionnaire

Feasibility questionnaires are useful, but sites tend to answer optimistically. A short pre-study site visit or qualification audit tells you far more: you see the storage room, the files, the staff and how the clinic actually runs.

For sponsors outside India, an independent local auditor can carry out these visits quickly and give an honest, documented assessment.

The payoff

Spending a little more effort at selection saves a great deal later. Fewer, better sites almost always outperform many weak ones.

Need an independent site qualification visit in India? Write to me at anup.cra@gmail.com.

– Anup Kumar, Independent Clinical Research Auditor & Consultant, New Delhi

Sunday, November 15, 2026

Sponsor Oversight: How to Supervise Your CRO Without Micromanaging

Outsourcing a trial to a CRO saves time and resources. But regulators are clear: you can outsource tasks, not accountability. ICH E6(R3) places strong emphasis on the sponsor's duty to oversee every service provider.

The challenge is getting the balance right. Too little oversight and you lose control of quality. Too much and you slow the study and damage the relationship. Here is a practical middle path.

1. Start with a clear contract and task list

A Transfer of Obligations or responsibility matrix should state exactly which tasks the CRO performs and which stay with the sponsor. Ambiguity here causes most oversight problems later.

2. Write an oversight plan

A short document (a few pages is enough) describing:

  • What you will review and how often
  • Which metrics you will track
  • When audits will happen
  • How issues will be escalated

This plan is your evidence of oversight for inspectors.

3. Track a few meaningful metrics

You don't need dozens of reports. Focus on indicators that reveal real quality:

  • Recruitment versus plan, by site
  • Protocol deviations per participant
  • Query rates and query ageing
  • SAE reporting timeliness
  • Monitoring visit frequency and report turnaround
  • Open action items from monitoring visits

Trends matter more than single numbers.

4. Hold structured meetings

Regular calls with an agenda, minutes and action items. Ask open questions: "Which site worries you most and why?" often reveals more than a status report.

5. Review a sample of the work yourself

Read a few monitoring visit reports in full. Look at the TMF. Check that issues raised by monitors are actually closed. Sampling is not micromanaging – it is verification.

6. Use independent audits and co-monitoring

An independent auditor or monitor gives you an unfiltered view of sites and the CRO's own processes. For overseas sponsors without staff in India, this is often the most efficient form of oversight. A few targeted visits can tell you whether what you see in reports matches reality.

7. Document everything

If you reviewed it, discussed it or decided something, record it. Inspectors judge oversight by evidence, not intention.

Signs your oversight isn't working

  • You learn about problems only at database lock
  • Monitoring reports all look the same
  • The same deviations repeat across visits
  • You can't easily answer "How is site X performing?"

Good oversight builds better partnerships

The best CROs welcome strong sponsor oversight. It clarifies expectations, catches problems early and makes the final inspection smoother for everyone.

Need an independent oversight partner for your trial in India? I provide sponsor-side monitoring, co-monitoring and CRO audits. Write to me at anup.cra@gmail.com.

– Anup Kumar, Independent Clinical Research Auditor & Consultant, New Delhi